Brief: 3Sbio Says Narfuraphine Hydrochloride Orally Disintegrating Tablets In Japan Approved For Market Launch

3SBio

05/07/2023 11:30

July 5 (Reuters) - 3SBio Inc  1530.HK :
    * NARFURAPHINE HYDROCHLORIDE ORALLY DISINTEGRATING TABLETS
CO-DEVELOPED BY 3SBIO AND TORAY IN JAPAN APPROVED FOR LAUNCH IN
MARKET


Further company coverage:  1530.HK 

 ((Reuters.Briefs@thomsonreuters.com;))